| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2026―Jul―13 |
Pharmacokinetics, safety, and efficacy of a generic molnupiravir formulation in healthy volunteers and ambulatory patients with COVID-19: a multicenter randomized two-stage clinical trial |
E.A. Antonova, S.M. Noskov, A.R. Dorotenko, V.V. Kovalik, V.V. Banko, M.L. Gefen, et al. (+3) Yu.D. Matvienko, I.E. Makarenko, R.V. Drai |
| 2 |
[GO] |
2026―Jul―13 |
Stable coronary artery disease after COVID-19: сlinical characteristics and factors associated with intact coronary arteries |
D.A. Derisheva, D.A. Yakhontov, L.D. Khidirova, V.L. Lukinov |
| 3 |
[GO] |
2026―Jul―13 |
Circulating microRNA profile associated with glucose metabolism disorders in patients after COVID-19 |
A.A. Nikulina, D.B. Sambur, O.V. Kalinina, A.S. Golovkin, K.A. Golovatyuk, T.L. Karonova |
| 4 |
[GO] |
2026―Apr―27 |
Bacterial microflora characteristics in hospitalized patients with COVID-19-associated community-acquired pneumonia in the Stavropol Territory |
N.E. Afanasyev, V.A. Baturin |
| 5 |
[GO] |
2026―Apr―27 |
Clinical characteristics of community-acquired pneumonia in patients with varying histories of prior COVID-19 infection |
E.A. Borodulina, B.E. Borodulin, K.V. Zhilinskaya, E.V. Yakovleva, L.V. Povalyaeva, S.A. Zubakina |
| 6 |
[GO] |
2025―Jun―17 |
Efficiency and safety of COVID-19 vaccines: a comparative analysis |
E.V. Reznik, A.S. Grigorievskaya, N.V. Vistovskaya, M.D. Iarovoi, I.V. Semenyakin, T.R. Kameneva |
| 7 |
[GO] |
2025―Jun―17 |
Community-acquired pneumonia in children after the COVID-19 pandemic. What influences the course and outcomes? |
D.V. Preobrazhenskaya, E.V. Melekhina, T.S. Sabinina, S.B. Yatsyshina |
| 8 |
[GO] |
2025―Jan―22 |
Increase in measles incidence during COVID-19 pandemic: risks of failure to the implementation of the international measles elimination program in the Russian Federation, the European Region, and globally between 2019 and 2024 |
E.Yu. Malinnikova, N.V. Yuminova, M.L. Maximov, M.A. Startseva, I.V. Pogarskaya, N.A. Kontarov |
| 9 |
[GO] |
2025―Jan―21 |
Risk factors for a poor distant outcome in patients with myocardial infarction depending on a history of COVID-19 |
V.V. Kashtalap, A.V. Sadovnikov, N.V. Sadovnikova, L.S. Gofman, E.D. Bazdyrev |
